SEARCH

SEARCH BY CITATION

References

  • 1
    Lerman C, Shields AE. Genetic testing for cancer susceptibility: The promise and the pitfalls. Cancer Nature Review 2004; 4: 235241.
  • 2
    Bancroft EK. Genetic testing for cancer predisposition and implications for nursing practice: Narrative review. Journal of Advanced Nursing 2010; 66: 710737.
  • 3
    Greco KG, Mahon SM. Genetics nursing practice enters a new era with credentialing. The Internet Journal of Advanced Nursing Practice 2003; 5: DOI: 10.5580/1450. Accessed 30 April 2012.
  • 4
    Badzek L, Turner M, Jenkins J. Genomics and nursing practice: Advancing the nursing profession. The Online Journal of Issues in Nursing 2008; 13: DOI: 10.3912/OJIN.Vol13No01Man01.
  • 5
    Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit L. Genetics, genomics, and cancer risk assessment: State of the art and future directions in the era of personalised medicine. CA: Cancer Journal for Clinicians 2011; 61: 327359.
  • 6
    Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: Recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling 2007; 16: 241260.
  • 7
    Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. Journal of Clinical Oncology 2000; 18: 24842492.
  • 8
    Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M, Ward RL. The role of BRCA mutation testing in determining breast cancer therapy. Nature Review Clinical Oncology 2010; 7: 708717.
  • 9
    King MC, Wieand S, Hale K et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP–P1) Breast Cancer Prevention Trial. Journal of the American Medical Association 2001; 286: 22512256.
  • 10
    Tamaki Y, Kotsuma Y, Miyoshi Y, Noguchi S. Breast cancer risk assessment for possible tailored screening for Japanese women. Breast Cancer 2009; 16: 243247.
  • 11
    Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine 2008; 10: 1932.
  • 12
    Diamandis M, White NM, Yousef GM. Personalized medicine: Marking a new epoch in cancer patient management. Molecular Cancer Research 2010; 8: 11751187.
  • 13
    Blumer H. Symbolic Interactionism: Perspective and Method. Goto M (tr.). Tokyo: Keisoshobo; [1969] 1991.
  • 14
    Strauss A, Cobin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Newbury Park, CA, USA: Sage, 1990.
  • 15
    Bonter K, Desjardins C, Currier N, Pun J, Ashbury FD. Personalised medicine in Canada: A survey of adoption and practice in oncology, cardiology and family medicine. BMJ Open 2011; 1: e000110.
  • 16
    Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature. Genetics in Medicine 2003; 5: 7076.
  • 17
    Bowera P, Macdonalda W, Harknessa E et al. Sibbald: Multimorbidity service organisation and clinical decision making in primary care: A qualitative study. Family Practice 2011; 28: 579587.
  • 18
    Nycum G, Avard D, Knoppers BM. Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. European Journal of Human Genetics 2009; 17: 872880.
  • 19
    Katapodi M, Northouse L, Pierce P, Milliron K, Liu G, Merajver S. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Oncology Nursing Forum 2011; 38: 572581.
  • 20
    Ready K, Arun BK, Schmeler KM et al. Communication of BRCA1 and BRCA2 genetic test results to healthcare providers following genetic testing at a tertiary care center. Familial Cancer 2011; 10: 673679.
  • 21
    Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH. BRCA mutation-negative women from hereditary breast and ovarian cancer families: A qualitative study of the BRCA-negative experience. Health Expect 2008; 11: 220231.
  • 22
    Wiederholt PA, Connor N, Hartig GK, Harari PM. Bridging gaps in multidisciplinary head and neck cancer care: Nursing coordination and case management. International Journal of Radiation Oncology, Biology, Physics 2007; 69: S88S91.
  • 23
    Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics 2005; 42: 749755.
  • 24
    Peshkin BN, DeMarco TA, Brogan BM, Lerman C, Isaacs C. BRCA1/2 testing: Complex themes in result interpretation. Journal of Clinical Oncology 2001; 19: 25552565.